Bentham Science Logo

CNS & Neurological Disorders - Drug Targets

Formerly: Current Drug Targets - CNS & Neurological Disorders

Volume 18, 10 Issues, 2019
ISSN: 1996-3181 (Online)
ISSN: 1871-5273 (Print)
This journal supports open access

Ranking and Category

  • 150th of 267 in

    Neurosciences

  • 119th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Most Cited Articles

Review Article

Oxidative stress: Major threat in traumatic brain injury

, 2018; 17(9): 689-695.

Nidhi Khatri, Manisha Thakur, Vikas Pareek, Sandeep Kumar, Sunil Sharma and Ashok Kumar Datusalia*


DOI: 10.2174/1871527317666180627120501


Research Article

Protective effect of kaempferol on the transgenic drosophila model of Alzheimer’s disease

, 2018; 17(6): 421-429.

Tanveer Beg, Smita Jyoti, Falaq Naz, Rahul, Fahad Ali, Syed Kashif Ali, Ahmed Mohamed Reyad and Yasir Hasan Siddique*


DOI: 10.2174/1871527317666180508123050


Review Article

Dl-3-n-butylphthalide (NBP): A promising therapeutic agent for ischemic stroke

, 2018; 17(5): 338-347.

Shan Wang, Fei Ma, Longjian Huang, Yong Zhang, Yuchen Peng, Changhong Xing, Yipu Feng, Xiaoliang Wang* and Ying Peng*


DOI: 10.2174/1871527317666180612125843



General Review Article

The underlying role of oxidative stress in neurodegeneration: A mechanistic review

, 2018; 17(3): 207-215.

Habib Yaribeygi, Yunes Panahi*, Behjat Javadi and Amirhossein Sahebkar*


DOI: 10.2174/1871527317666180425122557


Research Article

Development of a nasal donepezil-loaded microemulsion for the treatment of Alzheimer’s disease: In vitro and Ex vivo characterization

, 2018; 17(1): 43-53.

Lupe C. Espinoza, Marisol Vacacela, Beatriz Clares*, Maria Luisa Garcia, Maria-Jose Fabrega and Ana C. Calpena


DOI: 10.2174/1871527317666180104122347


Review Article

Neurotransplantation therapy and cerebellar reserve

, 2018; 17(3): 172-183.

Jan Cendelin, Hiroshi Mitoma* and Mario Manto


DOI: 10.2174/1871527316666170810114559


Review Article

Nf-κb as a key mediator of brain inflammation in Alzheimer’s disease

, 2019; 18(1): 3-10.

Chul Ju Hwang, Dong-Young Choi, Mi Hee Park and Jin Tae Hong*


DOI: 10.2174/1871527316666170807130011


Review Article

C-Abl inhibition; A novel therapeutic target for Parkinson’s disease

, 2018; 17(1): 14-21.

Abdelrahman Ibrahim Abushouk, Ahmed Negida*, Rasha Abdelsalam Elshenawy, Hossam Zein, Ali M. Hammad, Ahmed Menshawy and Wael M.Y. Mohamed


DOI: 10.2174/1871527316666170602101538



Review Article

Autophagy and mitochondria: Targets in neurodegenerative disorders

, 2018; 17(9): 696-705.

Ashutosh Kumar*, Amruta Dhawan, Alknanda Kadam and Akshada Shinde


DOI: 10.2174/1871527317666180816100203


Research Article

A novel combination of ω-3 fatty acids and nano-curcumin modulates interleukin-6 gene expression and high sensitivity C-reactive protein serum levels in patients with migraine: A randomized clinical trial study

, 2018; 17(6): 430-438.

Mina Abdolahi, Payam Sarraf, Mohammad Hassan Javanbakht, Niyaz Mohammadzadeh Honarvar, Mahsa Hatami, Neda Soveyd, Abbas Tafakhori, Mohsen Sedighiyan, Mona Djalali, Arash Jafarieh, Yousef Masoudian and Mahmoud Djalali*


DOI: 10.2174/1871527317666180625101643


Review Article

Non-invasive cerebellar stimulation in cerebellar disorders

, 2018; 17(3): 193-198.

Chiara Di Nuzzo, Fabiana Ruggiero, Francesca Cortese, Ilaria Cova, Alberto Priori and Roberta Ferrucci*


DOI: 10.2174/1871527317666180404113444


Review Article

Metabolic syndrome and its effect on the brain: Possible mechanism

, 2018; 17(8): 595-603.

Nurul ‘Ain Arshad, Teoh Seong Lin and Mohamad Fairuz Yahaya*


DOI: 10.2174/1871527317666180724143258


Review Article

Therapeutic advancement in alzheimer disease: New hopes on the horizon?

, 2018; 17(8): 571-589.

Ajeet Singh, Abshar Hasan, Sakshi Tiwari and Lalit M. Pandey*


DOI: 10.2174/1871527317666180627122448




Editor-in-Chief

Cesar V. Borlongan
Department of Neurosurgery and Brain Repair
University of South Florida Morsani College of Medicine
Tampa, FL
USA

Biography View Full Editorial Board

Journal History

Current Drug Targets - CNS & Neurological Disorders was launched in 2002 and later renamed in 2006 as CNS & Neurological Disorders - Drug Targets.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.13

Related Journals

Related eBooks

eBooks Catalog